The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.
Nasdaq: RIGL
Change
symbol:
     
 NEWS FROM THE WIRES
Rigel in deal with Novartis to find cancer drugs
Jul 31 2001 08:28 AM PDT

More WIRE STORIES about this company

 PROFILE
When immune systems attack, Rigel Pharmaceuticals wants to be there. The development-stage firm has a dozen research programs for such targets as asthma, allergy, hepatitis C, transplant rejection, chronic bronchitis, tumors, and such autoimmune conditions as rheumatoid arthritis and inflammatory bowel disease. It uses retroviruses to induce a disease-like response in cells, allowing for easier identification of targets for drug discovery. Rigel has collaborations with Cell Genesys; Janssen Pharmaceutica, a Johnson & Johnson unit; Novartis; and Pfizer.

 COMPETITION
Aventis (AVE)
Centocor, Inc. (dossier)
Immunex Corporation (IMNX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 13.20
1-Yr. Sales Growth: 46.7%
Employees: 107
Revenue per employee: $123,364.49

 KEY PEOPLE
• James M. Gower
    CEO
• Brian C. Cunningham
    CFO

 CONTACT INFO
240 E. Grand Ave.
South San Francisco, CA 94080
US
Phone: 650-624-1100
Fax: 650-624-1101
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001